Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,697 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval.
Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Piazza N, et al. Among authors: serruys pw. EuroIntervention. 2008 Aug;4(2):242-9. doi: 10.4244/eijv4i2a43. EuroIntervention. 2008. PMID: 19110790
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, Staberock M, de Feyter P, Müller R, Regar E, Degertekin M, Ligthart JM, Disco C, Backx B, Russell ME. Tanabe K, et al. Among authors: serruys pw. Circulation. 2003 Feb 4;107(4):559-64. doi: 10.1161/01.cir.0000048184.96491.8a. Circulation. 2003. PMID: 12566366 Clinical Trial.
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
Tanabe K, Serruys PW, Degertekin M, Guagliumi G, Grube E, Chan C, Munzel T, Belardi J, Ruzyllo W, Bilodeau L, Kelbaek H, Ormiston J, Dawkins K, Roy L, Strauss BH, Disco C, Koglin J, Russell ME, Colombo A; TAXUS II Study Group. Tanabe K, et al. Among authors: serruys pw. Circulation. 2004 Jan 20;109(2):196-200. doi: 10.1161/01.CIR.0000109137.51122.49. Epub 2003 Dec 22. Circulation. 2004. PMID: 14691036 Clinical Trial.
Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation.
Saia F, de Feyter P, Serruys PW, Lemos PA, Arampatzis CA, Hendrickx GR, Delarche N, Goedhart D, Lesaffre E, Branzi A; Lescol Intervention Prevention Study (LIPS) Investigators. Saia F, et al. Among authors: serruys pw. Am J Cardiol. 2004 Jan 1;93(1):92-5. doi: 10.1016/j.amjcard.2003.08.076. Am J Cardiol. 2004. PMID: 14697476 Free article. Clinical Trial.
Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial).
Aoki J, Ong AT, Arampatzis CA, Vijaykumar M, Rodriguez Granillo GA, Disco CM, Serruys PW. Aoki J, et al. Among authors: serruys pw. Am J Cardiol. 2004 Sep 1;94(5):627-31. doi: 10.1016/j.amjcard.2004.05.028. Am J Cardiol. 2004. PMID: 15342295
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.
Serruys PW, Ormiston JA, Sianos G, Sousa JE, Grube E, den Heijer P, de Feyter P, Buszman P, Schömig A, Marco J, Polonski L, Thuesen L, Zeiher AM, Bett JH, Suttorp MJ, Glogar HD, Pitney M, Wilkins GT, Whitbourn R, Veldhof S, Miquel K, Johnson R, Coleman L, Virmani R; ACTION investigators. Serruys PW, et al. J Am Coll Cardiol. 2004 Oct 6;44(7):1363-7. doi: 10.1016/j.jacc.2004.03.084. J Am Coll Cardiol. 2004. PMID: 15464314 Free article. Clinical Trial.
2,697 results